Kuros Biosciences AG
LSE:0RHR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Kuros Biosciences AG
LSE:0RHR
|
CH |
|
Aures Technologies SA
PAR:ALAUR
|
FR |
|
Kongsberg Gruppen ASA
OTC:KBGGY
|
NO |
|
G
|
Gr Sarantis SA
ATHEX:SAR
|
GR |
Wall St Price Targets
0RHR Price Targets Summary
Kuros Biosciences AG
According to Wall Street analysts, the average 1-year price target for 0RHR is 38.76 CHF with a low forecast of 38.38 CHF and a high forecast of 39.9 CHF.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 0RHR's stock price target?
Price Target
38.76
CHF
According to Wall Street analysts, the average 1-year price target for 0RHR is 38.76 CHF with a low forecast of 38.38 CHF and a high forecast of 39.9 CHF.
What is the Revenue forecast for Kuros Biosciences AG?
Projected CAGR
39%
Over the last 14 years, the compound annual growth rate for Revenue has been 38%. The projected CAGR for the next 3 years is 39%.
What is the Operating Income forecast for Kuros Biosciences AG?
Projected CAGR
95%
The compound annual growth rate for Operating Income over the next 3 years is 95%.
What is the Net Income forecast for Kuros Biosciences AG?
Projected CAGR
163%
The compound annual growth rate for Net Income over the next 3 years is 163%.
